|
|
“Excellent communication platform on hot topics of the biopharmaceutical industry”
Professor Rolf G Werner, Director Corporate Division Biopharmaceuticals, Boehringer Ingelheim
Stem cells & regenerative medicine is one of the most rapidly advancing areas of biology today. It has the potential to revolutionise the treatment of disease in a way once never thought imaginable. But like many expanding fields of scientific inquiry, research raises questions as rapidly as it generates new discoveries.
The promise of stem cell therapies is an exciting one, but significant technical hurdles remain that will only be overcome through years of intensive research. What is the potential for new medical treatments and what research is needed to make such treatments a reality are questions which remain paramount to all practitioners.
The European Stem Cells and Regenerative Medicine Congress will outline the pioneering research and commercial applications being conducted by academia and industry that are bringing successful cell-based treatments ever so closer to the clinic and beyond.
This congress is split into three distinct conference days, ensuring that all aspects of your professional activities are catered for in one succinct event.
- Pre-congress briefing day will cover applications in drug discovery and development, stem cell modelling, higher throughput screening environments and efficacy and safety assessment
- Congress day one will cover systems biology and stem cells, cell cultures and culture conditions and upscaling
- Congress day two will cover identifying therapeutic applications, realising therapeutic potential and commercialising therapeutic prospects
 
Meet, interact and do business with the people who really matter!
 This is a revolutionary, exciting, quick and non-pressured way to meet fellow conference delegates and industry peers in one 50-minute session. These brief meetings are the starting point for conversation and networking throughout the conference. This is where long-lasting and profitable business relationships begin. Make sure you bring plenty of business cards for this unique session! |
 We introduce you to ‘Contact’ – a system to enable you to set up meetings before the event. Better than most other online systems you can search the attendees then email them directly withour ever seeing their email address. We facilitate first contact and you take it from there. It is more that just on-line networking though, important documents and conference tips can be downloaded and after the event you can access the white papers and presentations from our world-class speakers. |
|
“Good speakers, many opportunities to network and well organised…”
Monica Ericsson, Senior Director, Biovitrum AB |
Who will sponsor? |
|
40+ industry presentations
17 case studies
15 hours of networking
10 countries represented
6 multi-speaker panel sessions
3 congress days
1 event!
|
|
Professor Ian Wilmut, Director, Centre for Regenerative Medicine, University of Edinburgh |
|
Dr Stephen L Minger, Director, Stem Cell Biology Laboratory, Wolfson Centre for Age-Related Diseases, King’s College London |
|
Dr Chris Mason, Director, Regenerative Medicine Bioprocessing Unit, University College London |
|
Dr Tim Allsopp, Chief Scientific Officer, Stem Cell Sciences |
|
Dr Thomas Okarma, Chief Executive Officer, Geron | |
| Pharmaceutical companies |
Contract Manufacturers |
| Reagent Supplier |
Processing Equipment Supplier |
| Contract Research Organisation |
IT or Instrument Supplier |
| Consultancy |
Law Firm |
| Regional or Government Investment Agency |
Contract Development and Manufacturing Service Provider |
| Venture Capitalist |
Protein Developer |
| Regional Biotech |
Process Engineering and Validation Service Provider |
|
Key benefits of sponsorship
Grow your business - sponsorship really works
- Get cost effective marketing exposure and branding to your target audience, culminating in fac-to-face meetings with your top prospects
- Position yourself as an industry leader
- Increase your brand recognition
- Create new partnerships and alliances
- Develop relationships through networking opportunities
- Showcase products and services to a targeted audience of real decision makers in the stem cells market
|
Previous sponsors and exhibitors of the bioLOGIC events include:
PALL Life Sciences, Lark Technologies, JRH Biosciences, Scottish Development International, Cardinal Health, Miltenyi Biotec, STEDIM, Lockwood Greene, ATMI Packaging, Berlinger & Co, Avecia, Solvay, Sartorius, Eden Biodesign, BioProcessors, Sandoz, Vetter-Pharma, HPA, Amersham Biosciences, ProMetic, DSM Biologics, Arup Biopharm Services, Laureate Pharma, NNE, Inveresk, Charter Medical, Werum, Rentschler, NUNC, Diosynth, HyClone, Xenova, HighTech Business Decision, Celliance, Biomedical Research Foundation, Cobra Biomanufacturing, Invitrogen, Terumo Medical Corp, Pharmadule Emtunga AB, ProMetic BioSciences, Cambrex BioSciences, DSM Biologics, Pittiglio Rabin Todd & McGrath (PRTM), WDA (Welsh Development Agency), PAA Laboratories GmbH, Patheon Inc, AppTec and BioProcessors. |
Stem cells have moved from biological obscurity to the forefront of the technological and political debate around the world.
The value of the stem cells market has been debated by many analysts and some have forecast a $10 billion market for stem cell technologies by 2010.
While others forecast $100m for stem cell therapies by the end of this decade, possibly growing to $2 billion by 2015. Whatever the estimates, the value of this growing industry represents real potential that merits your attention.
  
Confirm your future in stem cells & regenerative medicine today by calling Taz Shariff on +44 (0) 20 7827 4163 or email taz.shariff@terrapinn.com
|
|
